- Home
- MXL vs DYN Comparison
MXL vs DYN Comparison
Compare MXL & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXL
- DYN
- Stock Information
- Founded
- MXL 2003
- DYN 1984
- Country
- MXL United States
- DYN United States
- Employees
- MXL N/A
- DYN N/A
- Industry
- MXL Semiconductors
- DYN Medicinal Chemicals and Botanical Products
- Sector
- MXL Technology
- DYN Health Care
- Exchange
- MXL Nasdaq
- DYN Nasdaq
- Market Cap
- MXL 1.5B
- DYN 1.2B
- IPO Year
- MXL 2010
- DYN 2020
- Fundamental
- Price
- MXL $16.36
- DYN $9.95
- Analyst Decision
- MXL Buy
- DYN Strong Buy
- Analyst Count
- MXL 8
- DYN 15
- Target Price
- MXL $20.21
- DYN $43.07
- AVG Volume (30 Days)
- MXL 1.7M
- DYN 3.3M
- Earning Date
- MXL 07-23-2025
- DYN 08-11-2025
- Dividend Yield
- MXL N/A
- DYN N/A
- EPS Growth
- MXL N/A
- DYN N/A
- EPS
- MXL N/A
- DYN N/A
- Revenue
- MXL $378,015,000.00
- DYN N/A
- Revenue This Year
- MXL $24.12
- DYN N/A
- Revenue Next Year
- MXL $19.30
- DYN N/A
- P/E Ratio
- MXL N/A
- DYN N/A
- Revenue Growth
- MXL N/A
- DYN N/A
- 52 Week Low
- MXL $8.35
- DYN $6.36
- 52 Week High
- MXL $25.73
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- MXL 63.02
- DYN 52.19
- Support Level
- MXL $14.88
- DYN $8.95
- Resistance Level
- MXL $20.00
- DYN $9.58
- Average True Range (ATR)
- MXL 0.96
- DYN 0.58
- MACD
- MXL 0.08
- DYN 0.22
- Stochastic Oscillator
- MXL 39.03
- DYN 85.89
About MXL MaxLinear Inc.
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.